𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Activation of muscarinic receptors stimulates GABA release in the rat globus pallidus

✍ Scribed by Nathalie Kayadjanian; Annie Menétrey; Marie-Jo Besson


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
111 KB
Volume
26
Category
Article
ISSN
0887-4476

No coin nor oath required. For personal study only.

✦ Synopsis


The effect of carbachol on the spontaneous release of 3 H-GABA was investigated on rat globus pallidus (GP) slices. Carbachol dose-dependently enhanced the release of 3 H-GABA. The carbachol (5 3 10 24 M) induced 3 H-GABA release is mediated by muscarinic receptors since atropine (10 26 M), pirenzepine (10 26 M) and AF-DX384MS (10 26 M) abolished the effect. An indirect carbachol effect mediated by dopaminergic and glutamatergic afferents was ruled out since the effect was not blocked by either D1 (SCH23390 10 26 M) and D2 (sulpiride 10 25 M) receptor antagonists or by ionotropic glutamate receptor antagonists (CNQX 10 26 M and 10 25 M, MK801 10 26 M). A direct effect is further evidenced by the persistence of the carbachol effect in the presence of tetrodotoxin (5 3 10 27 M). Surprisingly the carbachol effect was not abolished by lowering the Ca 21 concentration of the superfusion medium or by increasing concomitantly the Mg 21 concentration. The involvement of a GABA transporter can partially explain this latter result, as nipecotic acid (10 23 M) blocked the effect by only 50%. Carbachol stimulated the accumulation of 3 H-phosphoinositides in pallidal slices, an effect that was antagonized by atropine (10 26 M), pirenzepine (10 26 M), and AF2DX384MS (10 26 M). These results suggest that the activation of muscarinic receptors localized on striatopallidal terminals stimulates the release of GABA in the globus pallidus through inositol phosphate hydrolysis.


📜 SIMILAR VOLUMES


The antiparkinsonian drug budipine stimu
✍ C.S. Biggs; A. Fisher; M.S. Starr 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

The present study examined the effects of the antiparkinsonian drug budipine on dopamine synthesis and release from L-DOPA in the substantia nigra of reserpine-treated rats. Budipine (at 100 microM, but not 10 microM) applied by reverse dialysis to the nigra caused a small and significant rise in do